Search - tctmd.com

Displaying 581 - 600 of 1207

Sort: Relevancy | Date

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

September 28, 2016

News Industry News

Zilver® PTX® with Thumbwheel Delivery System Launched in France

September 23, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

September 22, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

News Conference News PCR London Valves 2016

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

September 19, 2016

News Industry News

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

September 15, 2016

News Industry News

Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke

September 08, 2016

News Daily News

FDA Expands Indications for Two Endovascular Stroke Therapies

September 06, 2016

News Industry News

St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation

September 01, 2016

News Industry News

FDA Approves New AGGRASTAT® Product Format

September 01, 2016

News Conference News ESC 2016

Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4

August 31, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

August 24, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Industry News

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

August 15, 2016

News Industry News

GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease

August 02, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

August 01, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the X-Seal 6F Vascular Closure Device

August 01, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

July 28, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.